Historical returns of Inhibikase Therapeutics (id:6056 IKT)
Annual returns
| 2021 | 2022 | 2023 | YTD | |
|---|---|---|---|---|
| Inhibikase Therapeutics Inc | -79.47 % | -66.89 % | -56.36 % | 73.68 % |
| United States | 93.67 % (3234, Country_ID:6) | 1,141.71 % (3604, Country_ID:6) | 186.82 % (3638, Country_ID:6) | 27.83 % (3656, Country_ID:6) |
Trailing returns
| 1D | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | 16.67 % | 11.59 % | -10.81 % | 79.07 % | 73.68 % | 168.60 % | -41.37 % | 0.000 % | 0.000 % | 0.000 % |
| All United States stocks | 2.37 % | 3.39 % | 7.47 % | 13.93 % | 26.63 % | 45.94 % | -3.44 % | 5.67 % | 3.27 % | 6.90 % |
Monthly returns
| January | February | March | April | May | June | July | August | September | October | November | December | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 |
126.77 %
|
-28.95 %
|
-0.92 %
|
-33.18 %
|
28.67 %
|
-35.64 %
|
13.71 %
|
-0.71 %
|
-5.11 %
|
96.12 %
|
|
|
73.68 % |
2023 |
45.55 %
|
3.46 %
|
-15.25 %
|
-14.03 %
|
26.94 %
|
-9.85 %
|
-24.10 %
|
-22.69 %
|
-33.81 %
|
-35.33 %
|
6.59 %
|
41.11 %
|
-56.36 % |
2022 |
-7.28 %
|
-24.29 %
|
42.31 %
|
-25.77 %
|
-14.41 %
|
-19.18 %
|
17.99 %
|
11.58 %
|
-9.90 %
|
-17.85 %
|
-25.28 %
|
-19.35 %
|
-66.89 % |
2021 |
-6.98 %
|
-1.18 %
|
-10.96 %
|
-12.69 %
|
1.36 %
|
-47.66 %
|
-20.63 %
|
6.76 %
|
-18.80 %
|
3.65 %
|
0.00 %
|
-25.00 %
|
-79.47 % |
Avg |
39.51 %
|
-12.74 %
|
3.80 %
|
-21.42 %
|
10.64 %
|
-28.08 %
|
-3.26 %
|
-1.27 %
|
-16.91 %
|
11.65 %
|
-6.23 %
|
-1.08 %
|
73.68 % |